Clinical and microbiologic effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized chronic periodontitis: Smokers versus non-smokers

Journal of Periodontology

Volumn 85, Issue 4, 2014, Pages 581-591

  Faveri, Marcelo ^a   Rebello, Allisson ^a   De Oliveira Dias, Rafael ^a   Borges Junior, Ivan ^a   Duarte, Poliana Mendes ^a   Figueiredo, Luciene Cristina ^a   Feres, Magda ^a  

^a GUARULHOS UNIVERSITY   (Brazil)

Author keywords

Amoxicillin; Chronic periodontitis; Metronidazole; Nonsurgical periodontal debridement; Smoking.

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; METRONIDAZOLE;

ACTINOMYCES; ADULT; CHRONIC PERIODONTITIS; CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFECTS; EDUCATION; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MOUTH HYGIENE; MULTIMODALITY CANCER THERAPY; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTICS; PREVENTIVE DENTISTRY; PROCEDURES; SMOKING; TOOTH PLAQUE;

ACTINOMYCES; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHRONIC PERIODONTITIS; COHORT STUDIES; COMBINED MODALITY THERAPY; DENTAL PLAQUE; DENTAL PLAQUE INDEX; DENTAL SCALING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; ORAL HYGIENE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; ROOT PLANING; SMOKING;

EID: 84897414701     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2013.130278     Document Type: Article

References (50)

1. Gelskey SC. Cigarette smoking and periodontitis: Methodology to assess the strength of evidence in support of a causal association. Community Dent Oral Epidemiol 1999;27:16-24.
2. Thomson WM, Slade GD, Beck JD, Elter JR, Spencer AJ, Chalmers JM. Incidence of periodontal attachment loss over 5 years among older South Australians. J Clin Periodontol 2004;31:119-125.
3. Johnson GK, Guthmiller JM. The impact of cigarette smoking on periodontal disease and treatment. Periodontol 2000 2007;44:178-194.
4. Corraini P, Baelum V, Pannuti CM, Pustiglioni AN, Romito GA, Pustiglioni FE. Risk indicators for increased probing depth in an isolated population in Brazil. J Periodontol 2008;79:1726-1734.
5. Susin C, Oppermann RV, Haugejorden O, Albandar JM. Periodontal attachment loss attributable to cigarette smoking in an urban Brazilian population. J Clin Periodontol 2004;31:951-958.
6. Grossi SG, Genco RJ, Machtei EE, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995;66:23-29.
7. Martinez-Canut P, Lorca A, Magán R. Smoking and periodontal disease severity. J Clin Periodontol 1995; 22:743-749.
8. Bergström J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989;17:245-247.
9. Kazor C, Taylor GW, Loesche WJ. The prevalence of BANA-hydrolyzing periodontopathic bacteria in smokers. J Clin Periodontol 1999;26:814-821.
10. Haffajee AD, Socransky SS. Relationship of cigarette smoking to the subgingival microbiota. J Clin Periodontol 2001;28:377-388.
11. Gomes SC, Nonnenmacher C, Susin C, Oppermann RV, Mutters R, Marcantonio RA. The effect of a supragingival plaque-control regimen on the subgingival microbiota in smokers and never-smokers: Evaluation by real-time polymerase chain reaction. J Periodontol 2008;79:2297-2304.
12. Gomes SC, Piccinin FB, Oppermann RV, et al. Periodontal status in smokers and never-smokers: Clinical findings and real-time polymerase chain reaction quantification of putative periodontal pathogens. J Periodontol 2006;77:1483-1490.
13. Kumar PS. Smoking and the subgingival ecosystem: A pathogen-enriched community. Future Microbiol 2012;7:917-919.
14. Boström L, Linder LE, Bergström J. Clinical expression of TNF-alpha in smoking-associated periodontal disease. J Clin Periodontol 1998;25:767-773.
15. Boström L, Linder LE, Bergström J. Smoking and cervicular fluid levels of IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol 1999;26:352-357.
16. Söder B, Jin LJ, Wickholm S. Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 2002;29:384-391.
17. Fredriksson M, Bergström K, Asman B. IL-8 and TNF-alpha from peripheral neutrophils and acutephase proteins in periodontitis. J Clin Periodontol 2002;29:123-128.
18. Preber H, Linder L, Bergström J. Periodontal healing and periopathogenic microflora in smokers and nonsmokers. J Clin Periodontol 1995;22:946-952.
19. Kaldahl WB, Johnson GK, Patil KD, Kalkwarf KL. Levels of cigarette consumption and response to periodontal therapy. J Periodontol 1996;67:675-681.
20. Renvert S, Dahlén G, Wikström M. The clinical and microbiological effects of non-surgical periodontal therapy in smokers and non-smokers. J Clin Periodontol 1998;25:153-157.
21. Jin L, Wong KY, Leung WK, Corbet EF. Comparison of treatment response patterns following scaling and root planing in smokers and non-smokers with untreated adult periodontitis. J Clin Dent 2000;11: 35-41.
22. Wan CP, Leung WK, Wong MC, et al. Effects of smoking on healing response to non-surgical periodontal therapy: A multilevel modelling analysis. J Clin Periodontol 2009;36:229-239.
23. Trombelli L, Cho KS, Kim CK, Scapoli C, Scabbia A. Impaired healing response of periodontal furcation defects following flap debridement surgery in smokers. A controlled clinical trial. J Clin Periodontol 2003;30:81-87.
24. Papantonopoulos GH. Effect of periodontal therapy in smokers and non-smokers with advanced periodontal disease: Results after maintenance therapy for a minimum of 5 years. J Periodontol 2004;75: 839-843.
25. Labriola A, Needleman I, Moles DR. Systematic review of the effect of smoking on nonsurgical periodontal therapy. Periodontol 2000 2005;37:124-137.
26. Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol 2001;28:296-305.
27. Goodson JM, Haffajee AD, Socransky SS, et al. Control of periodontal infections: A randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. J Clin Periodontol 2012;39:526-536.
28. Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Microbiologic testing and outcomes of full-mouth scaling and root planing with or without amoxicillin/ metronidazole in chronic periodontitis. J Periodontol 2010;81:15-23.
29. Silva MP, Feres M, Sirotto TA, et al. Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: A randomized placebo-controlled clinical trial. J Clin Periodontol 2011;38:828-837.
30. Feres M, Soares GM, Mendes JA, et al. Metronidazole alone or with amoxicillin as adjuncts to nonsurgical treatment of chronic periodontitis: A 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol 2012;39:1149-1158.
31. Matarazzo F, Figueiredo LC, Cruz SE, Faveri M, Feres M. Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: A randomized placebo-controlled study. J Clin Periodontol 2008;35:885-896.
32. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
33. Ammenheuser MM, Hastings DA, Whorton EB Jr., Ward JB Jr. Frequencies of hprt mutant lymphocytes in smokers, non-smokers, and former smokers. Environ Mol Mutagen 1997;30:131-138.
34. Mestnik MJ, Feres M, Figueiredo LC, Duarte PM, Lira EA, Faveri M. Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol 2010;37:353-365.
35. Socransky SS, Smith C, Martin L, Paster BJ, Dewhirst FE, Levin AE. "Checkerboard" DNA-DNA hybridization. Biotechniques 1994;17:788-792.
36. Socransky SS, Haffajee AD, Smith C, Dibart S. Relation of counts of microbial species to clinical status at the sampled site. J Clin Periodontol 1991; 18:766-775.
37. Lang NP, Tonetti MS. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent 2003;1:7-16.
38. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
39. Matuliene G, Studer R, Lang NP, et al. Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss. J Clin Periodontol 2010; 37:191-199.
40. Pahkla ER, Koppel T, Naaber P, Saag M, Loivukene K. The efficacy of non-surgical and systemic antibiotic treatment on smoking and non-smoking periodontitis patients. Stomatologija 2006;8:116-121.
41. Berglundh T, Krok L, Liljenberg B, Westfelt E, Serino G, Lindhe J. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial. J Clin Periodontol 1998;25:354-362.
42. van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA. Smoking affects the subgingival microflora in periodontitis. J Periodontol 2001;72: 666-671.
43. Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol 2000 2006;42:180-218.
44. Matthews JB, Chen FM, Milward MR, et al. Effect of nicotine, cotinine and cigarette smoke extract on the neutrophil respiratory burst. J Clin Periodontol 2011; 38:208-218.
45. Güntsch A, Erler M, Preshaw PM, Sigusch BW, Klinger G, Glockmann E. Effect of smoking on crevicular polymorphonuclear neutrophil function in periodontally healthy subjects. J Periodontal Res 2006;41:184-188.
46. Palmer RM, Scott DA, Meekin TN, Poston RN, Odell EW, Wilson RF. Potential mechanisms of susceptibility to periodontitis in tobacco smokers. J Periodontal Res 1999;34:363-369.
47. Tipton DA, Dabbous MK. Effects of nicotine on proliferation and extracellular matrix production of human gingival fibroblasts in vitro. J Periodontol 1995;66:1056-1064.
48. Makino A, Yamada S, Okuda K, Kato T. Nicotine involved in periodontal disease through influence on cytokine levels. FEMS Immunol Med Microbiol 2008; 52:282-286.
49. Montalli VA, Bergamaschi Cde C, Ramacciato JC, et al. The effect of smoking on the bioavailability of metronidazole in plasma and saliva. J Am Dent Assoc 2012;143:149-156.
50. Pähkla ER, Koppel T, Saag M, Pähkla R. Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitis. J Clin Periodontol 2005;32:163-166.